United States · FDA National Drug Code directory
DAPAGLIFLOZIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70377-023_f23d20a0-8e57-6f45-e23b-0fffcb2f8652
- Product NDC
- 70377-023
- Form
- TABLET, FILM COATED
- Composition / generic term
- DAPAGLIFLOZIN
- Labeler
- Biocon Pharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260501
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPAGLIFLOZIN 2,3-BUTANEDIOL MONOHYDRATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70377-023-11) · 70377-023-11
- 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70377-023-12) · 70377-023-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →